Production of chemical pharmaceutical industry

---- Total production in the first half year of 2009 in China

This report has been released at 63^rd API China & INTERPHEX China Conference Program (November 2009).

Being affected by the drop in export, the 24 major chemical drug substance production and export provision in the first half of 2009 had a certain degree of drop, with the exclusion of the unreported figures, and the output dropping by a comparative 8%; volume of export provision decreased by a comparative 12.8%, the rate of drop was approximately 4 percentage points lower than the first quarter of the year.

Comparing the output of chemical and pharmaceutical preparations in the second quarter with that in the first quarter, the output of tablets, capsules and injection liquid all had a pronounced decrease, with tablets and capsules dropping by about 10 percentage points from the first quarter to second quarter, while output of injection liquid dropping from the first quarter (which was equivalent to that in the previous year) to the first half of the year by 7.5%. With the exclusion of unreported data, among the five major dosages of chemical preparations, intravenous instillation had a comparative increase of 34%, injectable powder (including the freeze-dry type) had a comparative increase of 13.7%, tablet and capsule output maintained the same level as that in the previous year among which sustained-release tablets had a comparative rise of 38.4%; injection liquid output dropped by 7.5% comparatively.

Comparison of the major export provision in the second quarter and that in the first quarter showed a slow-down in the decrease of the bulk output of the main category, among which the anti-infection drugs decreased by a corresponding 8.6%, which was 5 percentage points lower than the drop rate in the first quarter; the output of anti-pyretic analgesics remained the same as that in the first half of previous year but was 2 percentage points lower than the drop rate in the first quarter, export provision drop by 8.5%, which was 11 percentage points lower than the drop rate in the first quarter; output of vitamins fell by a comparative 15%, which was 13 percentage points lower than the decrease rate in the first quarter; while in the main category for the home market, cardiovascular system drugs had a comparative rise of 7%, which was 4 percentage points fall of the growth rate; output of anti-tumor drugs increased by 30% comparatively, and was 8 percentage points higher than that in the first quarter; while digestive system drugs made a u-turn, dropping from the growth of 16% in the first quarter to a fall of 15%, which was due to the closing-down of Shanghai Hongguang Chemicals Factory, causing a huge drop in the output of sodium bicarbonate.